Like other pandemics throughout human history, COVID-19 has caused profound changes that are still rippling through our societies, even as people are understandably eager to move on. In fact, these impacts are all the more dangerous when they are largely ignored or effectively invisible. The decline in adult vaccination may be one of the most significant, as a new report finds that ~100 million doses were missed in 2021 and 2022 alone – reversing global progress towards widespread adult immunisation as a new standard of care in a world of more old than young.

New data shared today by GSK, in collaboration with the IQVIA Institute for Human Data Science and the Global Coalition on Aging (GCOA), estimate approximately 100 million fewer doses of some adult vaccines (excluding Covid-19 vaccines) were administered in 2021 and 2022 than anticipated, based on the global vaccination adoption trends observed from 2013 to 2020, compounding already low adoption rates pre-pandemic.

The Global Coalition on Aging (GCOA) and Remnin University of China today released a new report highlighting adult immunization as a key opportunity for Beijing and other cities across China and the world to support healthy aging. Health aging is a critical goal for economies and societies that are increasingly shaped by the 21st century megatrend of aging.

The Global Coalition on Aging (GCOA), Immunize Canada, and other leading organizations across Canada have partnered on a unique public education campaign highlighting the need and opportunity for Canada’s caregivers to protect themselves against influenza.

New York, NEW YORK & Tokyo, JAPAN (August 5, 2019) – Today, the Global Coalition on Aging (GCOA) and the Health and Global Policy Institute (HGPI) published a new report, Measures to Ensure Healthy Ageing. The report connects economic growth and fiscal sustainability to healthy ageing and preventive healthcare measures, and points, in particular, to vaccines for adults as a key strategy.